Key result
A concurrent diagnosis of aortic aneurysm in patients undergoing transcatheter aortic valve replacement was not associated with a significant difference in in-hospital mortality compared to those without aortic aneurysm.
Why the study?
Data were limited regarding the outcomes of transcatheter aortic valve replacement among patients with thoracic or abdominal aortic aneurysms.
Does transcatheter aortic valve replacement have similar in-hospital outcomes in patients with versus without aortic aneurysm?
Cohort (n=29,517)
Yes
Does transcatheter aortic valve replacement have similar in-hospital outcomes in patients with versus without aortic aneurysm?
TAVR in patients with thoracic or abdominal aortic aneurysms is associated with similar in-hospital mortality and complication rates compared to patients without aneurysms, supporting its safety in this population.
Answers are grounded in this paper and cite their sources.
May support TAVR safety in aortic aneurysm; leaves open prospective confirmation before practice change.
INTRODUCTION: There is a paucity of data regarding the outcomes of transcatheter aortic valve replacement (TAVR) among patients with thoracic or abdominal aortic aneurysms (AA). Using the Nationwide Inpatient Sample (NIS) database, we explored the safety of TAVR among patients with a diagnosis of AA. METHODS: We queried the National Inpatient Sample database (2012-2017) for hospitalized patients undergoing TAVR, using ICD-9 and ICD-10 codes for endovascular TAVR. Reports show that > 95% of endovascular TAVR in the US is via transfemoral access, so our population are mostly patients undergoing transfemoral TAVR. Using propensity score matching, we compared the trends and outcomes of TAVR procedures among patients with versus without AA. RESULTS: From a total sample of 29,517 individuals who had TAVR procedures between January 2012 and December 2017, 910 had a diagnosis of AA. In 774 matched-pair analysis, all-cause in-hospital mortality was similar in patients with and without AA OR 0.63 [(95% CI 0.28-1.43), p = 0.20]. The median length of stay was higher in patients with AA: 4 days (IQR 2.0-7.0) versus 3 days (IQR 2.0-6.0) p = 0.01. Risk of AKI [OR 1.01 (0.73-1.39), p = 0.87], heart block requiring pacemaker placement [OR 1.17 (0.81-1.69), p = 0.40], aortic dissection [OR 2.38 (0.41-13.75), p = 0.25], acute limb ischemia [OR 0.46 (0.18-1.16), p = 0.09], vascular complications [OR 0.80 (0.34-1.89), p = 0.53], post-op bleeding [OR 1.12 (0.81-1.57), p = 0.42], blood transfusion [OR 1.20 (0.84-1.70), p = 0.26], and stroke [OR 0.58 (0.24-1.39), p = 0.25] were similar in those with and without AA. CONCLUSIONS: Data from a large nationwide database demonstrated that patients with AA undergoing TAVR are associated with similar in-hospital outcomes compared with patients without AA.
No takes yet. Share an insight, caveat, or question.
Ugwu et al. (2022) conducted a cohort in Aortic stenosis with aortic aneurysm (n=29,517). Aortic aneurysm vs. No aortic aneurysm was evaluated on All-cause in-hospital mortality (OR 0.63, 95% CI 0.28-1.43, p=0.20). A concurrent diagnosis of aortic aneurysm in patients undergoing transcatheter aortic valve replacement was not associated with a significant difference in in-hospital mortality compared to those without aortic aneurysm.
Synapse has enriched 10 related papers. Consider them for comparative context: